Gukovskaya A S, Pandol S J
Department of Medicine, Veterans Affairs Medical Center, San Diego, California, USA.
Am J Physiol. 1995 Jun;268(6 Pt 1):G900-7. doi: 10.1152/ajpgi.1995.268.6.G900.
Regulation of guanosine 3',5'-cyclic monophosphate (cGMP) formation by calcium and calcium-binding proteins was studied at the levels of nitric oxide synthase (NOS) and guanylyl cyclase (GC) in dispersed pancreatic acini isolated from guinea pig. In intact cells, in the cytosol, and on diethylaminoethyl fractions from cytosolic proteins, GC activity was negatively regulated by Ca2+. An increase in Ca2+ concentration ([Ca2+]) from 25 to 950 nM suppressed cGMP formation by 85%. On the other hand, NOS was stimulated by agents increasing cytosolic [Ca2+] and inhibited by intracellular Ca2+ chelators. Thus Ca2+ regulates cGMP production in opposite directions by activating NOS and inhibiting GC. Calmodulin antagonists W-7, trifluoperazine, and R-24571 inhibited NOS, suggesting that the enzyme is regulated by calmodulin as in other cell types. Calmodulin antagonists appeared to inhibit GC. In particular, 200 microM W-7 completely abolished the cGMP rise evoked by the nitric oxide donor, nitroprusside. The effect was not reversed by addition of excess calmodulin. The findings suggest that the negative regulation of GC by Ca2+ is due to factors other than calmodulin but affected by calmodulin antagonists.
在从豚鼠分离的分散胰腺腺泡中,研究了钙和钙结合蛋白对鸟苷 3',5'-环磷酸(cGMP)形成的调节作用,该调节作用发生在一氧化氮合酶(NOS)和鸟苷酸环化酶(GC)水平。在完整细胞、胞质溶胶以及胞质蛋白的二乙氨基乙基级分中,GC 活性受到 Ca2+的负调节。Ca2+浓度([Ca2+])从 25 nM 增加到 950 nM 可使 cGMP 形成减少 85%。另一方面,NOS 受到增加胞质[Ca2+]的试剂刺激,并被细胞内 Ca2+螯合剂抑制。因此,Ca2+通过激活 NOS 和抑制 GC 以相反方向调节 cGMP 的产生。钙调蛋白拮抗剂 W-7、三氟拉嗪和 R-24571 抑制 NOS,表明该酶与其他细胞类型一样受钙调蛋白调节。钙调蛋白拮抗剂似乎也抑制 GC。特别是,200 μM 的 W-7 完全消除了一氧化氮供体硝普钠引起的 cGMP 升高。添加过量钙调蛋白并不能逆转这种作用。这些发现表明,Ca2+对 GC 的负调节是由钙调蛋白以外的因素引起的,但受钙调蛋白拮抗剂影响。